On Tuesday Eastern Time, the three major U.S. stock indexes closed higher across the board, with both the Dow Jones Industrial Average and the S&P 500 Index hitting new all-time highs. The semiconductor sector showed significant strength due to a surge in prices triggered by a severe shortage of memory chips amid the AI boom, with Micron Technology leading the performance.
However, overnight, Cathie Wood did not blindly chase short-term trends but stuck to the underlying logic of disruptive innovation: increasing holdings $Roblox (RBLX.US)$ to bet on the generational revolution of the metaverse interaction paradigm, positioning $Kodiak AI (KDK.US)$ as anchoring the physical implementation of autonomous driving technology, while reducing holdings $Meta Platforms (META.US)$ is aimed at proactively 'cutting the fat and building muscle,' optimizing the risk-reward ratio of the portfolio.

Direction of increased positions: Buying Metaverse + Autonomous Driving
1. $Roblox (RBLX.US)$ Significantly added 169,100 shares, marking the most eye-catching move in this rebalancing.The market may be reassessing the value of gaming platforms in the generative AI era. Roblox, a platform with a vast young user base and UGC (user-generated content) ecosystem, is highly likely to be one of the best scenarios for the commercialization of AI tools. ARK's move could be a bet on an upcoming earnings turnaround or new product launch for RBLX.
2. $Kodiak AI (KDK.US)$ : Bought 39,300 shares,This represents ARK's continued focus on AI applications in vertical fields.
Direction of reduction: Sold Meta to optimize the portfolio
1. $Meta Platforms (META.US)$: Reduced holdings by 19,300 shares,Ms. Wood’s recent reduction in holdings does not indicate bearishness but is more like a standard 'rebalancing' strategy. Selling well-performing, large-market-cap stable stocks to free up cash for buying undervalued or deploying into higher-upside growth stocks like Roblox (RBLX), which may currently have more attractive valuations.
2. $Ionis Pharmaceuticals (IONS.US)$ & $Guardant Health (GH.US)$ARK reduced holdings in two biopharma stocks by 7,228 shares and 17,600 shares respectively, scaling back exposure to some biopharma individual stocks while focusing firepower on core high-conviction targets.

Risk Disclaimer: The above content only represents the author's view. It does not represent any position or investment advice of Futu. Futu makes no representation or warranty.Read more
Comments
to post a comment
4
7
